Pretransplant liver function status in patients with idiopathic portal hypertension-related ascites
| Parameter . | Value . |
|---|---|
| Alanine aminotransferase, U/L | |
| Median (n = 40) | 34 |
| Range | 12-223 |
| >2.5 ULN, n | 4 |
| Aspartate aminotransferase, U/L | |
| Median (n = 38) | 32 |
| Range | 16-146 |
| >2.5 ULN, n | 3 |
| Bilirubin, mg/dL | |
| Median (n = 40) | 0.6 |
| Range | 0.2-1 |
| >1.5 ULN, n | 0 |
| History of alcohol use, n | |
| Yes | 20 |
| No | 20 |
| History of viral hepatitis before allo-HSCT, n | |
| HBV | |
| HBsAg | 1 |
| HBcAb | 2 |
| HBV DNA | 1 |
| HCV | |
| HCV Ab | 1 |
| HCV RNA | 0 |
| Parameter . | Value . |
|---|---|
| Alanine aminotransferase, U/L | |
| Median (n = 40) | 34 |
| Range | 12-223 |
| >2.5 ULN, n | 4 |
| Aspartate aminotransferase, U/L | |
| Median (n = 38) | 32 |
| Range | 16-146 |
| >2.5 ULN, n | 3 |
| Bilirubin, mg/dL | |
| Median (n = 40) | 0.6 |
| Range | 0.2-1 |
| >1.5 ULN, n | 0 |
| History of alcohol use, n | |
| Yes | 20 |
| No | 20 |
| History of viral hepatitis before allo-HSCT, n | |
| HBV | |
| HBsAg | 1 |
| HBcAb | 2 |
| HBV DNA | 1 |
| HCV | |
| HCV Ab | 1 |
| HCV RNA | 0 |
HBcAb, hepatitis B core antibody; HBV DNA, hepatitis B DNA; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV Ab, hepatitis C virus antibody; HCV RNA, hepatitis C RNA; ULN, upper limit of normal.